Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE

Patients with eosinophilic severe asthma (SA) have an increased risk of asthma exacerbations. Benralizumab is approved for eosinophilic SA, and there is great value in understanding real-world effectiveness.

Source: Respiratory Medicine - June 6, 2023 Category: Respiratory Medicine Authors: Reynold A. Panettieri, Njira Lugogo, Wendy C. Moore, Bradley E. Chipps, Brett Jepson, Wenjiong Zhou, Christopher S. Ambrose, Eduardo Genofre, Donna D. Carstens Tags: Original Research Source Type: research